Related Experiment Video

Updated: Sep 28, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

[Protective vascular effect of angiotensin receptor blocker (ARB)]

Minoru Yamakado1

  • 1Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 26, 2002
PubMed

Insights

Angiotensin receptor blockers like candesartan reduce blood pressure and improve vascular health by decreasing oxidative stress. This study found candesartan improved carotid intima-media thickness, unlike diuretics, suggesting a mechanism beyond blood pressure reduction.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Hypertension Research

Background:

  • Essential hypertension is a major risk factor for cardiovascular disease.
  • Angiotensin receptor blockers (ARBs) are used to manage hypertension.
  • The precise mechanism of ARBs' vascular protective effects requires further elucidation.

Purpose of the Study:

  • To investigate the vascular protective mechanism of an ARB, candesartan.
  • To compare the effects of candesartan and diuretics on blood pressure and vascular markers.
  • To assess the role of oxidative stress in the vascular effects of candesartan.

Main Methods:

  • Twenty patients with essential hypertension were enrolled.
  • Effects on blood pressure (BP), carotid intima-media thickness (IMT), plasma superoxide dismutase (SOD), and lipid peroxides (LPO) were measured.
  • Comparisons were made between candesartan and diuretic treatment groups.

Main Results:

  • Candesartan and diuretics similarly reduced BP.
  • Candesartan significantly reduced IMT, while diuretics did not.
  • Candesartan increased SOD activity and decreased LPO, with significant correlations between IMT changes and oxidative stress markers.

Conclusions:

  • The vascular protective effects of ARBs, such as candesartan, may stem from their ability to counteract angiotensin-induced oxidative stress.
  • These beneficial effects appear to be independent of blood pressure reduction.
  • Targeting oxidative stress is a potential therapeutic strategy for hypertension-related vascular damage.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...